ABSA International
ABSA International

Resources with keywords: covid-19



Covid-19 vaccines and hearing loss and tinnitus (NEW 5/6, Website, News)
World Health Organization (WHO) - Pharmaceuticals Newsletter
29 April 2022

Rausch, C, et al
(No. 1, 2022) page 18

Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
29 April 2022

Clarke KE, Jones JM, Deng Y, et al.

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink (Website, Publication)
JAMA Network
26 April 2022

Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022;5(4):e228879. doi:10.1001/jamanetworkopen.2022.8879

Hanson KE, Goddard K, Lewis N, et al.

Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).

Updated Information on Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 Who are at Increased Risk for Severe Outcomes of COVID-19 (NEW 5/6, Website, Regulatory)
CDC/Health Alert Network (HAN)
25 April 2022
Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children (NEW 5/6, Website, Regulatory)
FDA
25 April 2022
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
22 April 2022

Shi DS, Whitaker M, Marks KJ, et al.

Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 (NEW 5/6, Website, Publication)
CDC/MMWR
15 April 2022

Plumb ID, Feldstein LR, Barkley E, et al.

Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Diagnostic Test Using Breath Samples (NEW 5/6, Website, Regulatory)
FDA
14 April 2022
Do I qualify for a COVID-19 vaccine booster and which one? (Website, Regulatory)
FDA

Use this chart to find out if you’re eligible for a COVID-19 vaccine booster and which one.

Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (Website, Regulatory)
FDA
29 March 2022

The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.

Go to Top